Today: 15 May 2026
Dollar Near 10-Month High as Iran War, Oil Shock and Fed Bets Squeeze Yen and Euro
30 March 2026
2 mins read

Dollar Near 10-Month High as Iran War, Oil Shock and Fed Bets Squeeze Yen and Euro

SINGAPORE, March 30, 2026, 19:06 SGT

The U.S. dollar hovered close to its highest levels in 10 months on Monday, heading for its strongest monthly performance since July, as diminished expectations for a swift resolution to the Iran conflict kept investors leaning on the greenback. The dollar index, tracking the currency against major rivals, last sat at 100.19 after peaking at 100.54 earlier in the month.

This shift is hitting more than just the FX crowd. Brent crude pushed past $115 a barrel, and with the dollar strengthening, importers are feeling an extra squeeze—oil and many food staples trade in dollars, making things costlier and fueling inflation headaches just as central banks reconsider what to do with rates.

Asia finds itself exposed. Reuters points out that the region snaps up nearly 80% of oil passing through the Strait of Hormuz, leaving officials from India to the Philippines grappling with a tough trio: accept weaker currencies, hike rates, or draw down reserves. Currencies were already under pressure before this hit, Natixis’s Alicia Garcia Herrero noted. “No easy policy options,” added Nomura’s Sonal Varma. Reuters

Chris Weston at Pepperstone flagged that the “playbook is to sell rallies in risk and maintain volatility hedges.” Bob Savage at BNY described this week’s batch of U.S. labor numbers as a “crucial run” for how the dollar trades next. The Bureau of Labor Statistics is set to release the March Employment Situation report on April 3. Reuters

The yen slipped past 160 per dollar—territory many traders flag as a red line since Tokyo’s July 2024 intervention—before clawing back to around 159.65. Japan’s chief currency official, Atsushi Mimura, cautioned that “decisive” measures could be on the table if speculative pressure continues. Meanwhile, BOJ Governor Kazuo Ueda left the door open to a possible rate hike as early as next month. Reuters

The euro managed to hold around $1.15, as traders ramped up bets that the European Central Bank would step in if rising energy prices pushed up inflation across the board. Policymaker Francois Villeroy de Galhau said the ECB was “ready to act” if it came to that. Commerzbank’s Thu Lan Nguyen pointed out that these expectations of ECB intervention were putting a floor under euro/dollar levels. Reuters

Sterling slipped further versus the dollar. As for the Australian and New Zealand dollars, both are on track for sharp March declines—a sign of the pressure on currencies exposed to energy imports or risk sentiment. The pound has shed 1.67% against the greenback this month; the Aussie is off 3.8%, and the kiwi is down 4.4%.

Wall Street’s been caught off guard by the rally. Bloomberg on Friday flagged that the Bloomberg Dollar Spot Index climbed roughly 2% in March. Last week, ING’s Chris Turner said it’s “too early to expect another major leg lower in the dollar,” noting that markets remain too complacent about the possibility of an extended Gulf crisis. Bloomberg.com

Still, the trade is looking crowded. According to Barclays, dollar sentiment is approaching “max bullish” territory, so positions are getting stretched. Pakistan, meanwhile, says it’s working to arrange talks between Tehran and Washington—though whether either side actually shows up remains to be seen. A diplomatic break, or even a softer U.S. payrolls number, could jolt the greenback off these highs. Reuters

Right now, the playbook hasn’t changed much: oil’s up, inflation’s hanging around, Fed cuts look less likely, and the dollar’s holding steady. According to Reuters, traders have shifted from expecting rate cuts to seeing about a 33% chance the Fed could actually hike before year-end. Central banks spanning from Tokyo to Manila are left trying to contain the fallout, not turn things around.

Stock Market Today

  • Key Advice for Investors: Focus on Long-Term Market Investment, Not Short-Term Fluctuations
    May 15, 2026, 6:19 AM EDT. The stock market has confounded many investors with strong returns despite economic challenges, including inflation and geopolitical tensions. The S&P 500 gained about 33% in the past year, the Dow rose roughly 23%, and the Nasdaq surged 47%. Experts caution against trying to predict short-term movements, which are highly volatile and influenced by unpredictable factors like trade tensions and supply disruptions. Historically, holding an investment such as an S&P 500 fund for longer periods significantly reduces the risk of losses. Short-term trading can result in locked-in losses and missed recovery gains, as illustrated by hypothetical scenarios involving the Vanguard S&P 500 ETF (VOO). Data shows one-year periods see negative returns 33% of the time, but this risk declines sharply over five- and ten-year horizons. Investors are advised to prioritize time in the market over timing it to enhance potential returns.

Latest articles

Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

Mobix Labs Stock Soars 79% After Rare-Earth Deal Plan — Why MOBX Is Suddenly in the China Supply-Chain Fight

15 May 2026
Mobix Labs shares jumped 78.74% to $3.11 Thursday after it signed a non-binding letter of intent to acquire Special Project Delivery, a U.S. critical-minerals and energy-storage platform. The company also amended a convertible note with Leviston Resources, raising principal to $4 million for $833,000 in new cash. SPD was formed in 2019 and is based in Newport Beach, California.
HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

HCW Biologics Stock News: Profit, Pipeline and Nasdaq Risk Put HCWB Back in Focus

15 May 2026
HCW Biologics posted first-quarter net income of $3.47 million on $6.54 million in revenue, reversing a year-earlier loss, after a licensing deal with Beijing-based Trimmune Biotech. The company remains below Nasdaq’s $1 minimum bid and awaits early human data from its lead autoimmune drug, HCW9302, in alopecia areata. HCW also reported positive animal study results for a lung drug targeting premature infants.
MicroAlgo Stock Jumps Before The Bell As Quantum Circuit Algorithm Puts MLGO Back In Play

MicroAlgo Stock Jumps Before The Bell As Quantum Circuit Algorithm Puts MLGO Back In Play

15 May 2026
MicroAlgo Inc. announced a new algorithm for automating quantum circuit design, sending its shares up 13.18% to $4.55 at Thursday’s close and 20.88% higher in pre-market trading Friday. The company said its tool can generate and evaluate quantum circuits without pre-set specs and tested it on standard problems, but did not disclose customers, pricing, or a launch date.
Datavault AI Stock Rises Before Q1 Results as Crypto Bill Vote Puts DVLT Back in Focus

Datavault AI Stock Rises Before Q1 Results as Crypto Bill Vote Puts DVLT Back in Focus

15 May 2026
Datavault AI shares climbed about 10% in early premarket trading ahead of its first-quarter results and webcast. The move follows a Senate committee vote advancing a crypto-market bill tied to Datavault’s tokenization strategy. The company recently raised $60 million in a stock sale to fund its GPU edge-network plan, raising dilution concerns. Shares were quoted at $0.5861, up from $0.55 in the recent offering.
Ciena Corporation Stock Swings After Insider Sale Filing as AI Networking Boom Gets Tested
Previous Story

Ciena Corporation Stock Swings After Insider Sale Filing as AI Networking Boom Gets Tested

Nvidia Stock Hits 7-Year Valuation Low Even as New AI Orders Roll In
Next Story

Nvidia Stock Hits 7-Year Valuation Low Even as New AI Orders Roll In

Go toTop